PACE Trial Steering Committee
The PACE Trial Steering Committee (or TSC) was "responsible for the independent oversight of the progress of the trial, investigation of serious adverse events, and determining the future progress of the trial in the light of regular reports from the DMEC" (Data Monitoring and Ethics Committee).[1] The Medical Research Council approved the members of the PACE Trial Steering Committee.[1]
The PACE Trial Steering Committee members were:
| Name | Role | Organization | Expertise |
|---|---|---|---|
| Prof Janet Darbyshire | Chair of TSC | ||
| Prof Jenny Butler | occupational therapist | ||
| Prof Patrick Doherty | physiotherapist | ||
| Dr Stella Harris | patient representative | ||
| Dr Meirion Llewelyn | consultant doctor in infectious diseases | ||
| Professor Tom Sensky | liaison psychiatrist and CBT therapist |
PACE TSC observers[edit | edit source]
| Name | Role | Organization | Expertise |
|---|---|---|---|
| Professor Mansel Aylward | observer | previously of the Dept. for Work and Pensions | |
| Mr Chris Clark | observer | Action for ME | |
| Peter Craig | observer | Scottish Executive | |
| Dr. Moira Henderson | observer | Dept. for Work and Pensions | |
| Susan Lonsdale | observer | Department of Health | |
| Dr Sarah Perkins | Medical Research Council | ||
| Professor Stephen Stansfeld | observer | Queen Mary University of London (a trial sponsor) | |
| Dr Alison Wearden | observer | Principal Investigator of the FINE trial, a "sister study to PACE") | Psychologist |
PACE Trial Principlal Investigators[edit | edit source]
| Name | Role | Organization | Expertise |
|---|---|---|---|
| Prof Peter White | Co-principal investigator | Queen Mary University of London | |
| Trudie Chalder | Co-principal investigator | Psychologist | |
| Michael Sharpe | Co-principal investigator | Oxford University | |
| Rebecca Walwyn | Trial statistician | ||
| Tony Johnson | Trial statistician | ||
| Julia DeCesare | Trial manager (secretary to the committee) |
Previous members/observers[edit | edit source]
Members/observers prior to March 2007.
| Name | Role | Organization | Expertise |
|---|---|---|---|
| Dr Robin Buckle | Medical Research Council | ||
| Prof Clair Chilvers | Department of Health | R & D |
Data Monitoring and Ethics Committee[edit | edit source]
The Data Monitoring and Ethics Committee (DMEC) was "independent and responsible for monitoring progress of the trial and serious adverse events and reactions". The DMEC was expected to meet at least once per year, and was to produce a "trial progress report" for each meeting.[1]
DMEC members were:
- Prof Paul Dieppe, Chair
- Dr Charlotte Feinmann, liaison psychiatrist
- Prof Astrid Fletcher, epidemiologist
PACE Trial Management Group[edit | edit source]
The separate PACE Trial Management Group (TMG) was "responsible for the day-to-day running and management of the trial".
First wave therapists[edit | edit source]
Therapists involved in piloting the therapies
Vincent Deary CBT
Nicola Dyer GET
Sally Ludlum APT
Louise Mason APT
Bella Stensnas CBT
Claire Topfer GET
Tracey Turner GET
Sally Wagner APT
Sue Wilkins CBT
Giselle Withers CBT
See also[edit | edit source]
Learn more[edit | edit source]
References[edit | edit source]
- ↑ 1.0 1.1 1.2 White, Peter D; Sharpe, Michael C; Chalder, Trudie; DeCesare, Julia C; Walwyn, Rebecca (March 8, 2007). "Protocol for the PACE trial: A randomised controlled trial of adaptive pacing, cognitive behaviour therapy, and graded exercise as supplements to standardised specialist medical care versus standardised specialist medical care alone for patients with the chronic fatigue syndrome/myalgic encephalomyelitis or encephalopathy". BMC Neurology. 7: 6. doi:10.1186/1471-2377-7-6. ISSN 1471-2377. PMC 2147058. PMID 17397525.
